Monday, 28 September 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Par Drugs & Chemicals Ltd

NSE: PAR · Pharmaceuticals & Biotechnology · 5 announcements

Share price: ₹131.41
Market cap: ₹161.7 Cr
Revenue (annual): ₹103.7 Cr
Net profit (annual): ₹13.11 Cr
P/E (TTM): 11.2×Sector 50.4×
Promoter holding: 73.41%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 2 Management Change 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

22 Aug 2026 17:53 IST NSE

Financial Results

Par Drugs & Chemicals Q4 FY26 Results: Net Profit ₹13.1 Cr, Down 2.2% YoY

Par Drugs & Chemicals Ltd reported revenue from operations of ₹103.7 Cr (+2.7% YoY) and net profit of ₹13.1 Cr (-2.2% YoY) for Q4 FY26.

Key figure: Net profit ₹13.1 Cr · -2.2% YoY

Open full results → Read the filing ↗

8 Aug 2026 17:23 IST NSE

Financial Results

Par Drugs & Chemicals Q1 FY27 Results: Net Profit ₹4.7 Cr, Up 42.4% YoY

Par Drugs & Chemicals Ltd reported revenue from operations of ₹31.3 Cr (+20.4% YoY) and net profit of ₹4.7 Cr (+42.4% YoY) for Q1 FY27.

Key figure: Net profit ₹4.7 Cr · +42.4% YoY

Open full results → Read the filing ↗